TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Galena Pharma Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
34,046
|
30,269 | |
Financial expenses |
10
|
91
|
105 |
Earnings before taxes |
3,396
|
192
|
2,084 |
Total assets |
19,708
|
14,643
|
13,227 |
Current assets |
1,751
|
1,854
|
8,355 |
Current liabilities |
9,988
|
10,359
|
6,128 |
Equity capital |
6,372
|
3,362
|
5,205 |
- share capital |
3,119
|
2,978
|
3,102 |
Employees (average) |
25
|
20
|
19 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
32.3%
|
23.0%
|
39.4% |
Turnover per employee |
1,702
|
1,593 | |
Profit as a percentage of turnover |
0.6%
|
6.9% | |
Return on assets (ROA) |
17.3%
|
1.9%
|
16.5% |
Current ratio |
17.5%
|
17.9%
|
136.3% |
Return on equity (ROE) |
53.3%
|
5.7%
|
40.0% |
Change turnover |
4,988
|
3,939 | |
Change turnover % |
17%
|
15% | |
Chg. No. of employees |
5
|
1
|
0 |
Chg. No. of employees % |
25%
|
5%
|
0% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.